Pharmacy

The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring and breathing difficulties. The approval marks the first new therapy for IPF approved in more than a decade. The…

The American Society of Health-System Pharmacists has named 10 hospitals as ASHP-certified Centers of Excellence in medication-use safety and pharmacy practice. The designation recognizes hospitals with high-quality pharmacy services and a demonstrated commitment to medication safety, continual improvement and advanced…

Colorado finalized the nation’s first prescription drug price cap Oct. 3, establishing an upper payment limit for Enbrel, an autoimmune medication, through the state’s prescription drug affordability review board, according to the board’s website. The rulemaking process began May 23…

Hospitals that serve a high volume of low-income and uninsured patients rely on Disproportionate Share Hospital (DSH) funding to maintain financial stability. A hospital’s DSH percentage is critical for preserving access to the 340B Drug Pricing Program. As healthcare policy continues to…

Amgen launched a direct-to-patient program Oct. 6 to offer its cholesterol medication Repatha at a reduced price. The AmgenNow program will provide Repatha for $239 per month — nearly 60% below the current U.S. list price — to all eligible…

Becker’s asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share their biggest growth opportunities.  The 8 executives featured in this article are all speaking at the Becker’s Healthcare Fall…

Costco and Novo Nordisk are teaming up to sell a month’s supply of Ozempic or Wegovy for $499 — a sharp discount for the two GLP-1 medications.  In an Oct. 3 post on X, Novo Nordisk announced the collaboration, which…

Rite Aid has closed its final 89 stores, bringing an end to operations after decades as one of the largest pharmacy chains in the U.S. “All Rite Aid stores have now closed. We thank our loyal customers for their many…

A recently announced initiative between Pfizer and the Trump administration to lower U.S. drug prices will likely have minimal effects at the pharmacy counter, The New York Times reported Oct. 1.  On Sept. 30, Pfizer CEO Albert Bourla, PhD, said…

The FDA approved Evita Solutions’ abbreviated new drug application for mifepristone 200 mg tablets, with the approval taking effect Sept. 30. The product was determined to be bioequivalent and therapeutically equivalent to Danco Laboratories’ Mifeprex 200 mg tablets, according to…